New EU Approvals

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add seven new products, including Winrevair, MSD's treatment for pulmonary arterial hypertension.

New EU Approvals
• Source: Shutterstock (Pixelvario)

The Pink Sheet’s regularly updated list of products containing new active substances that have been approved for marketing in the EU under the centralized authorization procedure now includes seven new products – Balversa, mRESVIA, Ordspono, Piasky, Tauvid, Winrevair and Adzynma.

The list, which contains information dating back to January 2018, comprises brand name, generic name, company, therapeutic indication, date of...

More from Europe

More from Geography